Belite Bio (NASDAQ:BLTE) Receives “Overweight” Rating from Cantor Fitzgerald
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. A number of other brokerages have also commented on BLTE. HC Wainwright reiterated a “buy” rating and issued a $100.00 target price on shares of Belite […]
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reissued by research analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. A number of other brokerages have also commented on BLTE. HC Wainwright reiterated a “buy” rating and issued a $100.00 target price on shares of Belite […]
